MedPath

Brugmann University Hospital

Brugmann University Hospital logo
🇧🇪Belgium
Ownership
Private
Established
1923-01-01
Employees
-
Market Cap
-
Website
http://www.chu-brugmann.be/en

Study of Myocardial Contractility After Cardiac Surgery Under an Anterograde or Retrograde Cardioplegia

Not Applicable
Completed
Conditions
Heart Arrest
Interventions
Procedure: Antegrade cardioplegia
Procedure: Retrograde cardioplegia
First Posted Date
2016-06-28
Last Posted Date
2017-11-22
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
20
Registration Number
NCT02816385
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

Evaluation of Cardiac Hemodynamic Modifications During Temporary Left Atrial Appendage Occlusion

Not Applicable
Completed
Conditions
Cardiac Surgery
Interventions
Device: Transesophageal echocardiogram
Device: Thermistor-tipped catheter
Device: Pressure/volume catheter
Device: Transthoracic echocardiography
First Posted Date
2016-06-28
Last Posted Date
2019-04-17
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
20
Registration Number
NCT02814851
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

MRI Analysis of Glycosaminoglycan Modifications Inside the Intervertebral Disk After Distraction and Posterior Fusion

Not Applicable
Completed
Conditions
Lumbar Spine Instability
Interventions
Device: Magnetic Resonance Imaging
First Posted Date
2016-06-28
Last Posted Date
2025-02-06
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
40
Registration Number
NCT02815696
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple Sclerosis

Not Applicable
Completed
Conditions
Multiple Sclerosis
Interventions
Other: Nine Hole Test
Device: Triple Stimulation Technique
First Posted Date
2016-06-20
Last Posted Date
2019-04-17
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
30
Registration Number
NCT02805634
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?

Not Applicable
Recruiting
Conditions
Hemophilia
Interventions
Device: Chronometric method
Device: Chromogenic method
Device: Thrombin generation test (TGT)
First Posted Date
2016-06-17
Last Posted Date
2023-07-28
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
50
Registration Number
NCT02803502
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

🇧🇪

HUDERF, Brussels, Belgium

🇧🇪

Centre Hospitalier Régional de la Citadelle de Liège, Liège, Belgium

and more 2 locations

Age Related D-dimer Evaluation for the Exclusion of a Left Atrium Thrombus in Patients With Atrial Fibrillation (ADDIT-AF)

Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Procedure: Blood sampling
First Posted Date
2016-06-16
Last Posted Date
2022-07-20
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
142
Registration Number
NCT02802488
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Device: Diffusion-weighted Nuclear Magnetic Resonance Imaging (MRI)
First Posted Date
2016-06-14
Last Posted Date
2020-01-18
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
61
Registration Number
NCT02798484
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

Effect of Levobupivacaine Infiltration on the Post Partum Perineal Pain in Episiotomy, in Primiparous Women After Instrumental Delivery

Phase 2
Withdrawn
Conditions
Episiotomy
Interventions
Other: Physiological serum
First Posted Date
2016-06-10
Last Posted Date
2018-07-13
Lead Sponsor
Brugmann University Hospital
Registration Number
NCT02796547
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

🇫🇷

CHU Montpellier, Montpellier, France

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Not Applicable
Completed
Conditions
Age-Related Macular Degeneration
Interventions
Device: Genotype analysis
First Posted Date
2016-05-04
Last Posted Date
2018-01-23
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
501
Registration Number
NCT02762188
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

Diffusion MRI (Magnetic Resonance Imaging) Using ADC (Apparent Diffusion Coefficient) Histograms in the Evaluation of Adnexal Tumor Aggressiveness

Completed
Conditions
Adnexal Tumor
Interventions
Other: Correlation of MRI results with clinical characteristics of the adnexal mass
First Posted Date
2016-04-19
Last Posted Date
2020-01-18
Lead Sponsor
Brugmann University Hospital
Target Recruit Count
126
Registration Number
NCT02742870
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath